HLHIX — AllianzGI Health Sciences Fund
Data updated: 2026-05-29
HLHIX — AllianzGI Health Sciences Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $89.76M AUM · 1.05% expense ratio · -0.8% 1-yr return. From SEC regulatory filings.
HLHIX Fund Overview
HLHIX — AllianzGI Health Sciences Fund is a US mutual fund managed by Virtus Investment Trust, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Virtus Investment Trust
- Category: United States Health Care Equity
- Assets under management: $89.76M
- 1-year return: -0.8%
- Ticker: HLHIX
- SEC CIK: 0000867297
- SEC series ID: S000007977
- Share class ID: C000150255
HLHIX Holdings
Top 10 holdings of AllianzGI Health Sciences Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Co. | 13.30% |
| Mckesson Corp. | 5.57% |
| Vertex Pharmaceuticals Incorporated | 5.09% |
| AbbVie Inc. | 5.09% |
| Merck & Co., Inc | 5.05% |
| Intuitive Surgical Inc. | 4.80% |
| West Pharmaceutical Services Incorporated | 4.40% |
| IDEXX Laboratories Inc. | 4.29% |
| Mettler-Toledo International Inc | 4.20% |
| The Cooper Companies, Inc. | 4.05% |
HLHIX Portfolio Allocation
Asset-class allocation of AllianzGI Health Sciences Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.2% |
HLHIX Performance
Total returns for HLHIX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -9.0% |
| 1 year | -0.8% |
| 3 years (annualised) | -0.5% |
| 5 years (annualised) | 1.2% |
HLHIX Risk Information
Risk metrics for HLHIX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.8%
HLHIX Costs and Fees
HLHIX costs about $105 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.05%
- Gross expense ratio: 1.15%
- Portfolio turnover: 8%
- Brokerage commissions: 1.32 bps of average net assets (SEC N-CEN)
HLHIX Cashflows
Over the 12 months to 2026-03, AllianzGI Health Sciences Fund had net outflows of $20.87M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$1.67M |
| 2026-02 | −$1.51M |
| 2026-01 | −$1.56M |
| 2025-12 | −$1.51M |
| 2025-11 | −$1.14M |
| 2025-10 | −$1.84M |
HLHIX Debt Constituents
No individual debt constituents are reported in AllianzGI Health Sciences Fund's latest SEC N-PORT filing.
HLHIX Prospectus and SEC Filings
Official AllianzGI Health Sciences Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.